Search - tctmd.com

Displaying 181 - 200 of 973

Sort: Relevancy | Date

Presentation TCT 2022

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Presenter: Eric Secemsky

September 19, 2022

Presentation TCT 2022

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

Presenter: Catalin Toma

September 19, 2022

Presentation TCT 2022

CDT: New Devices, Drugs, and Duration?

Presenter: Andrew Sharp

September 19, 2022

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

Presenter: Sanjum Sethi

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

TCT 832: Aspiration Thrombectomy: a Potential Treatment for Pulmonary Embolism in COVID-19

Presenter: Saahil Jumkhawala

September 18, 2022

Presentation TCT 2022

TCT 834: The immediate change in cardiac and hemodynamic physiology following catheter-directed alleviation of intermediate high-risk pulmonary embolism

Presenter: Antoon van den Enden

September 18, 2022

Presentation TCT 2022

TCT 830: FlowTriever Thrombectomy for “Intermediate Risk” Pulmonary Embolism in a Jehovah’s Witness Patient

Presenter: John Finley

September 18, 2022

Presentation TCT 2022

TCT 831: When you have nothing to lose you have everything to gain: Emergent percutaneous thrombectomy in a patient with cardiogenic shock and large mobile thrombus in the right atrium

Presenter: Sara Blasco-Turrion

September 18, 2022

Presentation TCT 2022

TCT 833: RV, the forgiving ventricle: RVAD associated right atrial thrombus

Presenter: Mohammad Hashim Jilani

September 18, 2022

Presentation TCT 2022

Innovation in Interventional PE Therapies

Presenter: Peter Monteleone

September 18, 2022

Presentation TCT 2022

Role of Drug-Eluting Technologies as Definitive Therapy

Presenter: Beau Hawkins

September 18, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

Presentation TCT 2022

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

Presenter: Melvin Lobo

September 17, 2022

Presentation TCT 2022

TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study

Presenter: Daniel Burkhoff

September 17, 2022

Presentation TCT 2022

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Presenter: Marc Bonaca

September 17, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

News Industry News

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

September 16, 2022

News Conference News ESC 2022

ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis

Shelley Wood

August 29, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

Advertisement

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

CDT: New Devices, Drugs, and Duration?

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

TCT 832: Aspiration Thrombectomy: a Potential Treatment for Pulmonary Embolism in COVID-19

TCT 834: The immediate change in cardiac and hemodynamic physiology following catheter-directed alleviation of intermediate high-risk pulmonary embolism

TCT 830: FlowTriever Thrombectomy for “Intermediate Risk” Pulmonary Embolism in a Jehovah’s Witness Patient

TCT 831: When you have nothing to lose you have everything to gain: Emergent percutaneous thrombectomy in a patient with cardiogenic shock and large mobile thrombus in the right atrium

TCT 833: RV, the forgiving ventricle: RVAD associated right atrial thrombus

Innovation in Interventional PE Therapies

Role of Drug-Eluting Technologies as Definitive Therapy

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis

What’s Going to Be Hot at ESC 2022?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content